April 24, 2026Journal of the American College of Cardiology
Select Drug-Drug Interactions With Direct Oral Anticoagulants
Key result
DOAC drug-drug interactions are linked to increased bleeding risk, requiring awareness to optimize management.
Why the study?
Drug-drug interactions involving DOACs represent an important contributor to increased bleeding risk, requiring awareness to optimize management and mitigate risk.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Prompts routine medication reconciliation in DOAC patients to lower bleeding; leaves open optimal interventions in complex polypharmacy.
Key Points
- This review aims to summarize the impact of drug-drug interactions on the management of direct oral anticoagulants.
- Overview of DOAC metabolism and common drug interactions
- Discussion of mechanisms leading to drug-drug interactions
- Strategies for mitigating bleeding risk associated with these interactions
- Identified major drug-drug interactions that increase bleeding risk in patients using DOACs.
- Explained the underlying mechanisms contributing to these interactions.
- Provided recommendations for management to optimize therapy and reduce bleeding risks.
Structured PICO
P
Population
Individuals requiring long-term treatment with an oral anticoagulant
I
Intervention
Direct oral anticoagulants (DOACs)
Understanding DOAC metabolism and drug-drug interactions is essential for optimizing anticoagulant therapy and minimizing bleeding risks.
Cite This Study
Wiggins et al. (2020) conducted a review in Patients requiring oral anticoagulation. Direct oral anticoagulants (DOACs) was evaluated. Drug-drug interactions involving direct oral anticoagulants represent an important contributor to increased bleeding risk, requiring awareness to optimize management and mitigate bleeding.